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                                                       ABSTRAK   
 
PENGENALAN: Andrographis paniculata (AP) adalah salah satu bentuk terapi 
alternatif yang popular untuk penyakit diabetes di Malaysia. Kementerian Sains dan 
Teknologi Malaysia telah memilih untuk memajukan piawaian (95%) ekstrak etanol 
(APE) sebagai rawatan yang efektif dan selamat untuk penyakit diabetes. 
Memandangkan kajian terdahulu menunjukkan pertikaian keputusan mengenai kesan 
AP ke atas sistem reproduktif lelaki, kajian ini dijalankan untuk menyelidik 
kemungkinan terdapat ketoksikan APE ke atas sistem reproduktif lelaki.  
 
OBJEKTIF: Mengkaji kesan 95% ekstrak etanol Andrographis paniculata (APE) ke 
atas kesihatan reproduktif jantan dalam tikus Sprague Dawley. 
 
BAHAN DAN KAEDAH: 50 tikus jantan dewasa yang sihat dibahagikan secara rawak 
kepada 5 kumpulan dengan 10 tikus setiap satu. Kumpulan 1, 2 dan 3 menerima tiga dos 
APE (10, 100 & 1000 mg/kg),  kumpulan 4 menerima glibenclamide (5 mg/kg) 
sementara kumpulan 5 menerima 2% CMC (vehikel). Berat badan direkodkan setiap 
minggu. Rawatan oral diberi sekali setiap hari selama 4 minggu dan kemudian setiap 
seekor tikus jantan dibiarkan mengawan dengan 3 ekor tikus betina sehinggalah 
kesemua tikus betina tersebut didapati positif dengan benih jantan atau di biarkan 
bersama maksima selama 2 minggu. Tikus jantan kemudiannya dikorbankan. Organ 
pembiakan ditimbang. Testis kiri digunakan untuk pengiraan jumlah spermatid, kauda 
kiri untuk pengiraan sperma dan kajian morfologi, sementara itu testis bahagian kanan 
digunakan untuk pemeriksaan histopatologi. 
 
 xv
KEPUTUSAN: Histologi testis menunjukkan bahagian oedema interstitial dengan 
spermatogenesis yang masih sempurna dalam kumpulan 1; sel kuman yang tidak 
tersusun, pertukaran sel yang tidak matang dan diameter tubular yang amat kecil dalam 
kumpulan 2 dan 3. Sel Leydig menunjukkan tetapi terdapat hyperplasia yang sederhana 
dalam kumpulan yang dirawat dengan APE. Organ reproduktif menunjukkan hala 
dimana timbangan yang lebih berat dalam kumpulan 1 dan  timbangan organ yang lebih 
ringan dalam kumpulan 2 dan 3 dibandingkan dengan kumpulan kawalan. Kiraan 
sperma: Kiraan spermatid dan pengeluaran sperma harian rendah secara signifikasi 
(p<0.01) dalam kumpulan 2 dan lebih rendah bagi kumpulan 3. Sperma abnormal lebih 
banyak di dapati di dalam kumpulan 2 dan 3. Tiada satu pun antara parameter yang 
dinyatakan di atas menunjukan perbezaan secara signifikan antara kumpulan 4 dan 5. 
 
PERBINCANGAN: APE memberi kesan negatif terhadap spermatogenesis melalui 2 
mekanism yang berbeza: 1) Peningkatan dalam peresapan kapilari 2) Kerosakan kepada 
fungsi sel Sertoli. Peningkatan peresapan kapilari menyebabkan peningkatan berat 
organ reproductif dalam kumpulan 1; sementara itu, kerosakan teruk spermatogenesis 
dalaam kumpulan 2 dan 3 yang disebabkan oleh kerosakan sel Sertoli menyebabkan 
organ yang lebih ringan dan kualiti sperma yang rendah. 
 
KESIMPULANNYA: Kesimpulannya, keputusannya menunjukkan rawatan APE 
mempunyai kesan negatif terhadap fungsi reproduktif tikus jantan yang bergantung 
kepada kadar dos yang diberi kepada tikus Sprague Dawley.                            
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                                                        ABSTRACT  
 
INTRODUCTION: Andrographis paniculata (AP) is one popular form of alternative 
therapy for diabetes mellitus in Malaysia. It is chosen by Ministry of Science and 
Technology, Malaysia to develop its standardized 95% ethanol extract (APE) as an 
effective and safe treatment of diabetes mellitus.  Since previous studies have shown 
conflicting results regarding effects of AP on male reproductive system, this study was 
undertaken to investigate possible male reproductive toxicity of APE. 
OBJECTIVES:   To study effects of 95% ethanol extract of Andrographis paniculata 
(APE) on male reproductive health in Sprague Dawley rats. 
MATERIALS AND METHOD: Fifty adult healthy male rats were randomly divided  
 
into 5 groups of 10 animals each.  Group 1, 2 and 3 received three different doses of 
APE (10, 100 & 1000 mg/kg), group 4 received glibenclamide (5mg/kg) while group 5 
received 2% CMC (vehicle). Treatment was administered once daily for 4 weeks 
premating and a maximum of 2 weeks mating period. Body weight was recorded 
weekly. Four weeks premating treatment was followed by mating of each male with 3 
female animals until all females were sperm positive or a maximum of 2 weeks. Male 
animals were then sacrificed. Reproductive organs were removed and weighed. Left 
testis was used for spermatid count, left cauda for sperm count and morphology while 
right testis was used for histopathological examination. 
RESULTS: Testicular histology showed severe interstitial edema of testis with intact 
spermatogenesis in group 1; progressively severe disorganized arrangement of germ 
cells, sloughing of immature cells and significantly smaller tubular diameter in groups 2 
and 3. However, Leydig cells showed mild hyperplasia in APE treated groups. 
Reproductive organ weight was high in group 1 and low in groups 2 and 3 when 
 xvii
 xviii
compared to control. Sperm count, spermatid count and daily sperm production were 
significantly low (p<0.01) in group 2 and were further reduced in group 3. Abnormal 
sperms were seen in groups 2 and 3. None of the above mentioned parameters showed 
significant differences between groups 4 & 5.  
DISCUSSION: APE adversely affects spermatogenesis by at least two different 
mechanisms: 1) Increase in capillary permeability 2) Damage to Sertoli cell 
functions. Increased capillary permeability has resulted into increased reproductive 
organ weight in group 1, while extensive damage to spermatogenesis in groups 
2 and 3, caused primarily by damage to Sertoli cells has resulted into low organ 
weight and poor semen quality. 
CONCLUSION: In conclusion, the results suggest that APE treatment adversely affects 
male reproductive functions in a dose-dependent manner in Sprague Dawley rats. 
 
 
 
 
                                                    
 
 
 
                                   
  
                                  CHAPTER 1.  INTRODUCTION 
                                   This chapter gives an overview of – 
                                    
 - herbal medicines and their ever increasing use in chronic diseases  
 
    such as diabetes mellitus 
 
 - diabetes mellitus, its prevalence and therapeutic options 
 
 - importance of research into safety profile of herbal medicines 
 
 - reproductive toxicity 
 
 - ICH and ICH guidelines for male reproductive toxicity studies 
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                                                  1. INTRODUCTION 
 
 
 
Herbs have been used for centuries to improve health and well being of mankind. 
Mainstream modern medicine is now beginning to re-focus on herbs and natural plant 
therapies as a primary means to deal with current-day health issues. Increasing use of 
herbal medicines in recent years is evidence of public interest in having alternatives to 
conventional medicine to treat various illnesses. Use of herbal medicine is very 
popular in South East Asia especially to treat chronic illnesses. In many developing 
countries, where access to hospitals and health care providers is limited, herbal 
medicines often are the only generally available form of medicine. Moreover, high 
cost and high incidence of adverse effects with these conventional drugs makes herbal 
medicines a more convenient choice in chronic illnesses such as diabetes mellitus.   
 
Diabetes mellitus is a serious, common and controllable chronic metabolic disorder 
that has a significant impact on health, quality of life, and life expectancy of patients. 
Due to its chronicity and life long treatment, it is a great burden on the health care 
systems of developed as well as developing nations. Prevalence of diabetes in adults 
worldwide was estimated to be 4.0% in 1995 and is expected to rise to 5.4% by the 
year 2025. The number of adults with diabetes in the world will rise from 135 million 
in 1995 to 300 million in the year 2025 (King et al., 1998). The aging of populations 
and the effects of modernization of lifestyle have led to a dramatic increase in the 
prevalence of diabetes globally with very high rates in developing nations, particularly 
in Asia and the Pacific (Amos et al., 1997). In Malaysia, high prevalence of diabetes 
mellitus is a growing concern. In Second National Health and Morbidity Survey 
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prevalence of diabetes mellitus in Malaysia was found to be 8.2%. The earlier survey 
done in 1986 had shown a prevalence of 6.3 % (NHMS, 1996).  
 
Diabetes mellitus is a multisystem disorder caused by absolute or relative deficiency 
of pancreatic insulin. Insulin controls the amount of glucose/sugar in blood by 
controlling the rate at which glucose is metabolized. Deficiency of insulin gives rise 
to abnormally high levels of glucose in blood stream. Prolonged high levels of blood 
glucose leads to damaged blood vessels, which may cause eye disease, heart disease, 
nerve damage (neuropathy) in internal organs and extremities, kidney disease 
(nephropathy), and foot ulcers. 
 
Conventional therapeutic options to treat diabetes mellitus include dietary control, 
physical exercise, oral antidiabetic drugs and insulin. Besides the conventional 
therapy, alternative therapies with antihyperglycaemic effects are increasingly sought 
by patients with diabetes. This comes as no surprise since alternative treatments have 
been widely used in chronic diseases, which may be only partially alleviated by 
conventional treatment. Alternative therapies with anti-diabetic activity have been 
researched extensively, particularly in Asia. One such popular form of alternative 
therapy for diabetes mellitus in Malaysia is Andrographis paniculata, which belongs 
to plant family Acanthaceae and is locally known as Hempedu Bumi. Due to its 
promising and high commercial potential, Ministry of Science and Technology, 
Malaysia has chosen Hempedu Bumi to develop its standardized 95% ethanol extract 
as an effective and safe treatment of diabetes mellitus. Advanced herbal preparations, 
often processed in a way that establishes relatively fixed chemical parameters are 
often called standardized extracts. Herbal medicines are commonly used by herbal 
 3
practitioners for medicinal effects in one of the three forms: 
 
1. Tinctures – These are typically made using an alcohol and water mixture as the 
solvent. The herb is first soaked in the solvent for a specified amount of time 
depending on the herb. This soaking period is usually from several hours to several 
days in length, and some herbs may be soaked for much longer period of time. The 
resultant solution is then pressed out, yielding the tincture.  
 
2. Fluid extracts – These are more concentrated than tinctures. Although they are most 
often made from hydro-alcoholic mixtures, other solvents may also be used such as 
vinegar, glycerine, propylene glycol, etc. Commercial fluid extracts usually are made 
by distilling off some of the alcohol, typically by using methods that do not require 
elevated temperature, such as vacuum distillation and counter-current filtration. 
However, some small manufacturers produce fluid extracts in a similar manner to 
tinctures via “cold percolation" process.  
 
 3. Solid extract - is produced by further concentration of the extract by the 
mechanisms described above as well as by other techniques such as thin layer 
evaporation. The solvent is completely removed from the solution, leaving a viscous 
extract which is soft and semisolid or a dry solid extract depending upon the plant, 
portion of the plant, or solvent used, or if a drying process was used. The dry solid 
extract, if not already in powdered form, can be ground into coarse granules or a fine 
powder.  
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Herbalists argue that their herbal therapies are cheap, available in remote areas, and 
above all, they are effective. However physicians want more evidence regarding 
safety and efficacy of traditional remedies. World Health Organization has recognized 
the importance of research in the field of herbal medicines. According to first ever 
document on global WHO traditional medicine strategy titled WHO Traditional 
Medicine Strategy 2002 –2005 “The use of traditional medicine is increasing rapidly 
in developed countries. In many parts of the world, policy-makers, health 
professionals and the public are wrestling with questions about the safety, quality, 
availability, preservation and further development of this type of health care. If 
traditional medicine is to be promoted as a source of healthcare, efforts must be made 
to promote its rational use, and identification of the safest and most effective therapies 
will be crucial”. 
 
Over the past decade important safety issues associated with the use of herbal 
products have resulted in regulatory action world-wide in an effort to protect public 
health. To receive a marketing authorization, herbal medicines are required to meet 
safety, quality and efficacy criteria in a similar manner to any other licensed medicine. 
One of the important aspects of safety profile of a pharmaceutical preparation is that it 
should not cause reproductive toxicity.   
 
Reproductive toxicity includes the toxic effects on the formation and maturation of 
male and female gametes, sexual function, the events surrounding the fusion of 
gametes and the development of the fertilized ovum. It also includes nourishment and 
transport of the conceptus within the genital tract, implantation, embryogenesis, 
intrauterine growth, placentation and placental function, parturition, lactation and 
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neonatal survival. Adverse reproductive effects in males are considered as significant 
as adverse effects occurring in females. 
 
To ensure the safety, and to evaluate possible male reproductive health-related 
problems associated with the use of APE, we investigated its effects on male 
reproductive system in Sprague Dawley rats according to guidelines proposed by 
International Conference on Harmonisation (ICH guidelines 2000)  of technical 
requirements for registration of pharmaceuticals for human use. 
 
The ICH initiative, which started in 1990, is an interregional venture covering 17 
high-income countries. It includes drug regulatory authorities of the European Union, 
Japan, and USA, assisted by the research-based pharmaceutical industry associations 
of those countries. ICH is a joint initiative involving both regulators and industry as 
equal partners in the scientific and technical discussions of the testing procedures, 
which are required to ensure and assess the safety, quality and efficacy of medicines. 
 
The ICH guidelines are produced by groups of eminent specialists drawn from the  
regulatory authorities and pharmaceutical companies of the ICH countries. Their 
scientific level is high and they represent an up-to-date approach to technical 
requirements. The costs related to full implementation of the guidelines are 
considerable, but it is argued that they are offset by more rapid registration of new 
drugs in the ICH countries. In June 1993 an ICH Harmonised Tripartite Guideline on 
Detection of Toxicity to Reproduction for Medicinal Products was adopted by the 
ICH Steering Committee and has since been implemented in the three ICH regions. In 
March 1999 it was proposed that active dissemination of the guidelines and their 
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adoption by some non-ICH countries have led to a growing perception that they 
represent international standards. 
 
Therefore in this study to investigate effects of APE on male reproductive system, we 
adopted ICH guidelines (An Addendum to the ICH Guideline, 2000) to ensure the 
reliability and safety of APE before it is recommended for human consumption. 
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                          CHAPTER 2. REVIEW OF LITERATURE 
       This chapter gives a summary of previously done research work related to  
                     − Andrographis paniculata (AP) 
      - antihyperglycaemic and other therapeutic benefits of AP 
                    - male reproductive system – its anatomy and physiology  
                    - male reproductive toxicity parameters   
                   -  male reproductive toxicity of AP- an issue still unclear.    
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                                               2. REVIEW OF LITERATURE  
 
2.1 ANDROGRAPHIS PANICULATA (AP)  
 
Andrographis paniculata  (Figure 4.1) is among many local herbs in South East Asia, 
and is claimed to have medicinal properties. It is also known as “King of Bitters," and 
is a member of plant family Acanthaceae. Local name of the plant is “Hempedu 
Bumi”. It is cultivated quite easily since it grows in all types of soil. Moreover, it 
grows in soil types where almost no other plant can be cultivated, particularly 
"serpentine soil," which is relatively high in aluminium, copper and zinc. Such 
hardiness helps account for its wide distribution. It grows abundantly in south-eastern 
Asia: India, Pakistan and Indonesia and is cultivated extensively in China and 
Thailand, the East and West Indies, and Mauritius (Gupta et al., 1990).  AP is an 
annual branched, erect - running 1/2 to 1 meter in height. Its stem is dark green, 2 - 6 
mm in diameter, quadrangular with longitudinal furrows and wings at angles of the 
younger parts. The leaves are opposite, decussate, lanceolate, up to 8 cm long and 
broad, glabrous, margin entire, and venation pinnate; the petiole is very short. The 
flowers are small with bilabial corollas. The fruits are small 2-celled odorless capsules 
which taste intensely bitter. The aerial parts of the plant (leaves and stems) are used to 
extract the active phytochemicals. 
 
Four well known diterpene lactones found in the plant AP include andrographolide, 
neoandrographolide, 14-deoxy-11, 12-didehydroandrographolide and 14- deoxy 
andrographolide. All of these have been isolated from the leaves (Basak et al., 1999). 
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Jain et al., (2000) used high pressure liquid chromatography to determine the amount 
of three major diterpenoids, andrographolide and neoandrographolide and 14-deoxy- 
11, 12- didehydro andrographolide in AP leaf extract. The primary medicinal 
component of AP is andrographolide. It has a very bitter taste and is colorless 
crystalline in appearance. Other active components include homoandrographolide, 
andrographan, andrographon, andrographosterin, and stigmasterol. Both growing 
region and seasonality play a role to determine the concentration of these diterpene 
lactones. The highest concentration of the active components is found just before the 
plant blooms. The HPLC method developed by Jain et al., (2000) is simple, rapid and 
precise and therefore can be used to determine concentration of active components in 
various extracts of AP. 
 
2.2 PHARMACOKINETIC AND ORAL BIOAVAILABILITY OF 
ANDROGRAPHOLIDE  
 
Panossian et al., (2000) determined the amount of andrographolide, the most active 
phytochemical of the plant AP in the blood plasma of rats and human volunteers 
following the oral administration of AP extract and AP fixed combination Kan Jang 
tablets using validated analytical methods (HPLC and GC-MS). Results of their study 
showed that andrographolide was quickly and almost completely absorbed into the blood 
following the oral administration of AP at a dose of 20 mg/kg body weight in rats. Its bio-
availability, however, decreased four-fold when a 10-times-higher dose was used. A large 
part (55 %) of andrographolide is bound to plasma proteins. Renal excretion is not the 
main route for eliminating andrographolide. Maximum plasma levels were reached after 
1.5-2 hours, as quantified by using a UV diode-array detection method. Half-life and 
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mean residence times were 6.6 and 10.0 hours, respectively. 
 
2.3 ANTIHYPERGLYCAEMIC ACTIVITY OF AP 
 
AP is used as a folk medicine remedy for diabetes mellitus in Malaysia. 
Borhanuddin et al., (1994) investigated hypoglycaemic effects of AP on non-
diabetic rabbits. Their study showed that water extract of AP in a dose of 10 mg/kg 
body weight can prevent induction of hyperglycaemia (P < 0.001) induced by oral 
administration of glucose 2 mg/kg body weight. However it failed to do so in 
adrenaline induced hyperglycaemia. It also failed to demonstrate any "fasting blood 
sugar lowering effect" upon chronic administration (6 weeks) of AP. 
 
Zhang & Tan, (2000) investigated antihyperglycaemic effects of 80% ethanolic 
extract of the aerial parts of AP in normal and streptozotocin (STZ)-induced diabetic 
rats. The extract was administered orally at 3 dose levels (0.1, 0.2, and 0.4 g/ kg body 
weight). At the end of the 14 day period, the extract significantly increased body 
weight (P < 0.01) and reduced fasting serum glucose in diabetic rats (P < 0.001) when 
compared with vehicle. Liver and kidney thiobarbituric acid-reactive substances 
(TBARS) levels were significantly lower (P < 0.0001, P < 0.005, respectively), 
whereas liver glutathione concentrations were significantly higher (P < 0.05) in 
extract treated diabetic rats compared with vehicle-treated diabetic rats. The extract 
significantly increased the activity of superoxide dismutase and catalase, but had no 
significant effect on glutathione peroxidase activity in diabetic rats. The results of the 
study showed that ethanolic extract of AP significantly lowered the blood glucose 
levels in diabetic rats and this effect was dose dependent. This experiment also 
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demonstrated reduced oxidative stress in diabetic rats. The authors postulated that anti 
hyperglycaemic effect of extract was possibly due to potentiation of insulin action and 
direct glucose lowering effect. Increased glucose metabolism may also partially be 
responsible for its hypoglycaemic effect. Moreover, the additional 
hypotryglyceridemic effect seen in the study is also beneficial in diabetic state. 
However, other possible mechanism(s) remain unclear. 
 
In another study conducted by Kartini, et al., (2000) antihyperglycaemic effects of 
ethanol extract of AP were investigated in STZ induced diabetic rats. After 3 weeks 
of treatment, treated rats had not only significant fall in blood glucose level but also 
had increased survival rate.  
 
 
2.4 OTHER THERAPEUTIC BENEFITS OF AP 
 
 
2.4.1 Hepatoprotective 
AP is claimed to possess hepatoprotective properties. Hepatoprotective activity of 
andrographolide was studied by Handa & Sharma, (1990). Acute hepatitis was 
induced in rats by single dose of galactosamine (800 mg/kg, 
intraperitoneal)/paracetamol (3g/kg, orally). Hepatoprotective activity was 
monitored by estimating liver enzymes (GOT and AST), alkaline phosphatase and 
bilirubin in serum, hepatic triglycerides, and by histopathological changes in the 
livers of experimental rats. Treatment with AP led to complete normalization of 
toxin-induced increase in the levels of all the five biochemical parameters, and 
significantly ameliorated toxin-induced histopathological changes in the livers of 
experimental rats. 
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Rana & Avadhoot, (1991) studied hepatoprotective effects of AP against carbon 
tetrachloride-induced liver damage. Alcoholic extract of the leaves of AP was 
obtained by cold maceration and a dose of 300 mg/kg of the extract was selected for 
the study. The extract was found to be effective in preventing liver damage that was 
evident by morphological, biochemical and functional parameters.  
 
In another study by Visen et al., (1993) andrographolide, the active constituent 
isolated from the plant AP, showed a significant dose dependent (0.75-12 mg/kg 
body weight orally for 7 days) protective activity against paracetamol-induced 
toxicity on ex vivo preparation of isolated rat hepatocytes. It completely antagonized 
the toxic effects of paracetamol on certain enzymes (GOT, AST and alkaline 
phosphatase) in serum as well as in isolated hepatic cells. Andrographolide was 
found to be more potent than silymarin, a standard hepatoprotective agent.  
 
2.4.2 Cardioprotective 
 
Effects of AP extracts on cardiovascular system have been investigated by many      
researchers. Zhao & Fang, (1991) investigated antithrombotic and myocardial 
protective properties of AP.  In this study the endothelium of the left anterior 
descending coronary artery of 16 dogs was injured mechanically. In the group 
pretreated with AP extract there was no elevation of the ST segment but plasma 6-k-
prostaglandin F1 alpha and platelet cyclic adenosine monophosphate were increased. 
The production of thromboxane and aggregation of platelets were inhibited, and no 
thrombus or myocardial infarction was induced when compared with control group.  
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The hypotensive activity of an aqueous extract of AP was studied using chronic 
intraperitoneal infusions by osmotic pumps (Zhang & Tan, 1996). The extract 
exhibited a dose-dependent hypotensive effect on the systolic blood pressure of 
spontaneously hypertensive rats (SHR). Plasma, but not lung acetylcholine esterase 
activity and kidney thiobarbituric acid level were significantly lower in extract-treated 
SHR when compared with vehicle-treated SHR controls.  This experiment showed 
that the aqueous extract of AP lowers systolic blood pressure in the SHR possibly by 
reducing circulating acetylcholine in the plasma as well as by reducing free radical 
levels in the kidneys. 
 
In the study by Zhang et al., (1998) the cardiovascular activity of 14-deoxy-11, 12-
didehydro andrographolide (DDA) from AP was elucidated in anaesthetized Sprague-
Dawley rats and isolated rat right atria. DDA produced significant fall in mean arterial 
blood pressure and heart rate in a dose-dependent manner. In the isolated right atria, 
DDA caused negative chronotropic action and antagonized isoproterenol-induced 
positive chronotropic action in a non-competitive and dose-dependent manner. These 
results further supported the bradycardia-inducing and beta-adrenoceptor antagonistic 
properties of DDA in vivo.  
 
Burgos et al., (2000) investigated effects of 70% ethanol extract of AP leaves on 
calcium homeostasis in rat vas deferens. The possible blockade of voltage operated 
calcium channels by AP extract was compared with that of verapamil. The results of 
their experiment indicate that AP blocks the uptake of calcium by selectively blocking 
voltage operated calcium channels in a dose dependent and non competitive manner 
thereby causing smooth muscle relaxation. Based on these findings authors suggested 
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the possible utility of AP extracts in the treatment of diseases such as arterial 
hypertension. 
 
2.4.3 Anti-inflammatory and Antipyretic activities 
AP is known to have anti-inflammatory activity and is used in many countries to relieve 
pain, sore throat and fever. In one randomized double blind study by Thamlikitkul et al., 
(1991) to assess the efficacy of AP, patients received either paracetamol or 3 g/day of 
AP or 6 g/day of AP for 7 days.  Efficacy of paracetamol or high dose AP was 
significantly more than that of low dose AP at day 3 in terms of the relief of fever and 
sore throat. However, the clinical effects were not different at day 7. Minimal and self 
limiting side effects were found in about 20 per cent of patients in each group. 
 
Another study was conducted to measure the effectiveness of standardized extract of 
AP in reducing the prevalence and intensity of symptoms and signs of common cold as 
compared with a placebo (Caceres et al., 1999). One hundred and fifty eight patients 
were divided in two equal size groups, one of which received AP dried extract (1200 
mg/day) and the other a placebo for a period of 5 days. It was concluded that AP had a 
high degree of effectiveness in reducing the prevalence and intensity of the symptoms 
in uncomplicated common cold beginning at day two of treatment. No adverse effects 
were observed or reported.  
 
Two randomized double-blind, placebo-controlled parallel group clinical trials were 
conducted by Melchior et al., (2000), a pilot study and a phase III study. They 
investigated the effect of a standardized extract (SHA-10) of AP fixed combination 
(Kan jang) in the treatment of uncomplicated upper-respiratory tract infections. 
 15
Medication was taken three times daily for a minimum of 3 days and a maximum of 8 
days for the pilot study, and for exactly three days in the phase III study. The primary 
outcome measures were patient’s self-evaluation of pain in the muscles, cough, throat 
symptoms, headache, nasal symptoms, eye symptoms and temperature. The physician's 
fixed score diagnosis was based mainly on sign/symptoms related to ear, nose, oral 
cavity, lymph glands-tonsils and eyes. The total symptom score showed a tendency 
toward improvement in the pilot study (p = 0.08), while both the total symptom score 
and total diagnosis score showed highly significant improvement (p <  0.0006 , p < 
0.003) in the treatment group as compared with the placebo. In both studies, throat 
symptoms/signs showed the most significant improvement.  
 
2.4.4 Anti-parasitic 
 
Dutta & Sukul, (1982) observed that water decoction of the leaves of AP killed the 
microfilaria of Dipetalonema reconditum in 40 min (in vitro). Three subcutaneous 
injections of the extract in infected dogs at 0.06 ml per kg body-weight reduced the 
number of microfilariae in blood by more than 85%. The larvae were not totally 
eliminated with more injections but the reduced microfilarial level persisted. No toxic 
effect of the extract was observed. 
 
In vitro and in vivo studies done by Najib et al., (1999) revealed that Malaysian 
medicinal plants, Piper sarmentosum, AP and Tinospora crispa produced considerable 
antimalarial effects. Chloroform extract showed better effects than the methanol extract 
in vitro. The chloroform extract of AP showed complete parasite growth inhibition with 
a dose as low as 0.05 mg/ml within 24 h incubation period. Methanol extract of AP was 
effective at the dose of 2.5 mg/ml and under incubation time of 48 hr. In vivo activity of 
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AP also demonstrated higher antimalarial effect than other two plant species. 
 
Zaridah et al., (2001) tested five aqueous extracts from three plant species, i.e., dried 
husks, dried seeds and dried leaves of Xylocarpus granatum (Meliaceae), dried stems of 
Tinospora crispa (Menispermaceae) and dried leaves of AP (Acanthaceae), in vitro, 
against adult worms of subperiodic Brugia malayi. The relative movability value of the 
adult worms over the 24-h observation period was used as a measure of the antifilarial 
activity of the aqueous extracts. Dried seeds extract of X. granatum demonstrated the 
strongest activity, followed by the dried leaves extract of AP, dried stems extract of T. 
crispa, dried husks extract and dried leaves extract of X. granatum.  
 
2.4.5 Immunostimulant and Anti-HIV 
Immunostimulant properties of AP have also been investigated by some researchers. 
Ethanolic extract and purified diterpene andrographolides of AP induced significant 
stimulation of antibody and delayed type hypersensitivity response to sheep red blood 
cells in mice (Puri et al., 1993). The plant preparations also stimulated non-specific 
immune response in the animals, measured in terms of macrophage migration index, 
phagocytosis of 14C-leucine labelled Escherichia coli and proliferation of splenic 
lymphocytes. The stimulation of both antigen specific and non-specific immune 
response was, however, of lower order with andrographolide than with the ethanolic 
extract, suggesting thereby that substance(s) other than andrographolide present in the 
extract might also be contributing towards immunostimulation. 
 
Basak et al., (1999) investigated the effects of diterpenes from AP and their succinoyl 
esters on clinically important proprotein convertases -1, -7 and furin. These convertases 
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are a group of enzymes involved in post-translational modification of a variety of 
proteins. These proteins include a wide range of hormones, neuropeptides, growth 
factors, coagulation factors, cell-surface receptor proteins as well as surface viral 
glycoproteins. Among the individual components of AP, neoandrographolide exhibited 
the highest inhibitory action with an IC50 of 53.5 micromol against furin. 
Andrographolide showed significant inhibitory activity against above mentioned 
enzymes only after succinoylation. Authors attributed this strong inhibitory action to 
structural modification of andrographolide molecule and suggested possibility of 
development of a new class of non-peptide inhibitors of proprotein convertases. 
Authors also suggested that this inhibitory action might be responsible for reported anti-
HIV property of 14-deoxyandrographolide succinic acid monoester. 
 
A phase I dose-escalating clinical trial of andrographolide from AP was conducted in 13 
HIV positive patients and five HIV negative, healthy volunteers (Calabrese et al., 2000). 
The objectives were primarily to assess safety, tolerability, effects on plasma virion 
HIV-1 RNA levels and CD4 (+) lymphocyte levels. No subjects used antiretroviral 
medications during the trial. Those with liver or renal abnormalities were excluded. The 
planned regimen was 5 mg/kg body weight for 3 weeks, escalating to 10 mg/kg body 
weight for 3 weeks, and to 20 mg/kg body weight for a final 3 weeks. The trial was 
interrupted at 6 weeks due to adverse events including an anaphylactic reaction in one 
patient. All adverse events had resolved by the end of observation. A significant rise in 
the mean CD4 (+) lymphocyte level of HIV subjects occurred after administration of  
10 mg/kg andrographolide (from a baseline of 405 cells/mm3 to 501 cells/mm 3;  
p = 0.002). There were no statistically significant changes in mean plasma HIV-1 RNA 
levels throughout the trial. 
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As is evident from the above description, AP has a wide range of therapeutic 
applications. Therefore investigation into its possible toxic effects is extremely 
important before it can be recommended for human consumption. As stated in the 
previous chapter, reproductive toxicity forms an important aspect of safety profile of 
any pharmaceutical preparation. The present study was designed to investigate possible 
toxic effects of AP on male reproductive system.  
 
2.5 MALE REPRODUCTIVE SYSTEM AND MALE REPRODUCTIVE 
TOXICITY PARAMETERS. 
 
The male reproductive system consists of a number of individual organs acting 
together to produce functional spermatozoa, and to deliver these spermatozoa to the 
female reproductive tract.  These organs include the testicles and epididymides 
(suspended in the scrotal sac), the vas deferens that leads to penile urethra and the 
accessory sex glands. The testis is central to the male reproductive system. It is the 
organ which generates the haploid germ cell by the process of spermatogenesis and it 
is the site of androgen production. Testicular spermatozoa are non-motile and 
incapable of fertilization. The function of the epididymis is to bring testicular 
spermatozoa to maturity. Mature sperm are stored in the lower portion, or tail, of the 
epididymis, cauda epididymis. The vas deference begins at the cauda epididymis then 
turns sharply upward along the posterior margin of the testes. Each vas deferens joins 
the duct from the adjacent seminal vesicle (one of the accessory glands) to form a 
short ejaculatory duct. Each ejaculatory duct passes through the prostate gland and 
empties into the urethra. The accessory glands of the male reproductive system are the 
seminal vesicles, prostate gland, and the bulbourethral glands. These glands secrete 
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fluids that enter the urethra. Thus semen consists of sperms in fluid secreted by 
accessory glands (De Kretser et al., 1982).  
 
The testicular tissue is organized into two compartments: the tubular compartment and 
the interstitium (Figure 2.1). The seminiferous tubules are the functional units of testis 
and are lined by seminiferous epithelium, which consists of Sertoli cells and germinal 
cells. The tubules are surrounded by the peritubular myoid cells. The interstitium is 
composed of Leydig cells, macrophages, fibroblasts, and blood vessels. These 
structures are embedded in the extracellular matrix. Spermatogenesis is a biological 
process within the seminiferous epithelium by which precursors termed 
spermatogonia undergo a complex series of divisions to give rise to spermatozoa 
(Gnessi et al., 1997).  
 
During the process of spermatogenesis the germ cells undergo a three distinct phases 
of development. 1) Mitosis- Proliferation of spermatogonia type A to leptotene 
spermatocytes. 2) Meiosis -Proliferation of leptotene spermatocyte to haploid 
spermatids. 3) Spermeiogenesis – Maturation of spermatids into spermatozoa. In the 
rat these stages follow one another giving rise to wave of spermatogenesis along the 
length of seminiferous tubules. By using periodic acid-Schiff staining, 14 stages of 
spermatogenesis can be identified in the seminiferous epithelium of rat. 
Spermatogenesis cycle takes 12-14 days to complete in rats. The germ cells in 
different stages of development are found at different levels from base of the tubule to 
lumen and are surrounded by the cytoplasm of somatic cells; the Sertoli cells (Cheng 
& Mruk, 2002). 
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The Sertoli cell cytoplasm extends the entire height of seminiferous epithelium 
because these cells nurture the germ cells through their cycles of development. The 
Sertoli cells cytoplasm surround the adjacent germ cells in an arboreal pattern and 
controls the radially directed organization of cell associations. The cytoplasm of 
Sertoli cells consists of a framework of microtubules (Fawcett, 1975) and 
intermediate filaments known as vimentin (Amlani & Vogl, 1988). As the germ cells 
divide and mature they move from basement membrane through tight junctional 
complexes of adjacent Sertoli cells until they reach the adluminal surface. The Sertoli-
Sertoli cell junctions form the blood-testis barrier, which helps to protect the germ 
cells from potentially harmful blood borne chemicals (Hess, 1999). Besides Sertoli-
Sertoli cells junctions, Russell, (1977) observed desmosome like junctions between 
Sertoli cells and germ cells (spermatogonia, spermatocytes and non-elongate 
spermatids) in the adult rat testis. As a result of this morphological intimacy between 
Sertoli and germ cells extensive interactions and communications take place between 
these cells throughout spermatogenesis both at biochemical and molecular level and 
germ cells largely rely on Sertoli cells not only for structural and nutritional support 
but also to coordinate various events of spermatogenesis (Cheng & Mruk, 2002). 
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Figure 2.1 Schematic representation of the anatomical arrangement of the adult rat 
testis.                                                                                                                                                                
 
 
 
It is well known that the essential prerequisite for normal testicular development and 
maintenance of spermatogenesis is the controlled secretion of LH, FSH, and testicular 
androgen during fetal and postnatal life (Gnessi et al., 1997). LH stimulates Leydig 
cells to secrete testosterone (testicular androgen), which is an absolute requirement for 
normal spermatogenesis. There are no receptors for FSH or testosterone on germ cells 
but Sertoli cell contains receptors for both FSH and testosterone, therefore these two 
hormones act through Sertoli cells (McLachlan et al., 1995).  Thus Sertoli cells play 
the key role in spermatogenesis by not only controlling the radial arrangement of 
germ cells, surrounding environment of germ cells and by expressing receptors for 
FSH and testosterone but also by their ability to produce locally, a range of proteins, 
the paracrine factors, which are essential for spermatogenesis (Griswold, 1995). 
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The complexity of the whole process of spermatogenesis explains its marked 
sensitivity to toxic substances. Toxicity to male reproductive system in rats can be 
assessed by a number of parameters.  
1. Fertile capability of male animals (rats) can be assessed by male reproductive 
performance study. This allows calculation of some reproductive indices, 
which are good indicators of fertile capability of male. These indices include: 
index of libido= (number mated/number paired) ×100, quantal pregnancy= 
(number pregnant/number mated) ×100, fertility index= (number 
pregnant/number paired) ×100 (Ratnasooriya & Dharmasiri, 2001). 
2. The second parameter of importance is quality of semen. Researchers 
investigate the quality of semen by sperm count, sperm motility and sperm 
morphology assay. The sperms from cauda epididymis are most frequently 
used for analysis, as fully mature sperms are stored in cauda (De Kretser et 
al., 1982). Various methods for semen analysis are used. In the study 
conducted by Ratnasooriya & Dharmasiri (2001), the spermatozoa in the 
right cauda epididymis were extruded into a definite amount of isotonic 
saline and the number of spermatozoa was counted on a hemocytometer 
under the microscope. Total number was expressed as number of sperms per 
cauda epididymis.  The gross morphology of spermatozoa can be observed 
using the above suspension. Ali et al., (2004) used above suspension for 
quantitation of percentage of morphologically abnormal sperms. They first 
stained it with 1% eosin and then evaluated microscopically (40× power). 
200 sperms per animal were counted and divided into normal, abnormal head 
and abnormal tail types. 
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3. To investigate damaging effect on spermatogenesis and sperm maturation, 
changes in reproductive organ weight, homogenization resistant spermatid 
head count from testis and histopathology of testis are most often used 
parameters. Damaging effects on spermatogenesis invariably affect the 
reproductive organ weight therefore significant changes in this parameter can 
be a good indicator of reproductive toxicity (Ratnasooriya & Dharmasiri, 
2001). Step 17–19 spermatids survive homogenization and can be counted in 
a hemocytometer. In the rat, developing spermatids spend about 6.3 days in 
these steps (Clermont & Harvey, 1965). Thus, daily sperm count can be 
calculated by dividing the number of spermatids determined, on a per-testis 
basis, by 6.3 (Crissman et al., 2000, Ali et al, 2004). Histopathological 
evaluation of testis allows direct examination of the site of spermatogenesis 
and detection of damaging effects. Qualitative examination gives an overall 
view of presence or absence of any abnormalities in testicular tissue whereas 
quantitative assessment of histopathology allows statistical comparison 
between groups. A number of parameters have been used by researchers for 
quantitative assessment of changes in histopathology of testis. Hessl & Nakai, 
(2000) used changes in testicular weight and percentage of tubules showing 
sloughing of germ cells to assess damage to testicular tissue caused by 
fungicide benomyl in male rats. The same parameters were also used by 
Sheri et al., (2001) while studying effects of Indenopyridine CDB-4022 on 
seminiferous tubules and D’Souza, (2003) for study of effects of tamoxifen 
on seminiferous tubules. Tubular differentiation index (TDI) is another 
parameter which gives a quantitative assessment of damage to 
spermatogenesis and was defined by Meistrich & Van Beek, (1993) as the 
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